Diversified Trust CO Travere Therapeutics, Inc. Transaction History
Diversified Trust CO
- $3.3 Billion
- Q4 2024
A detailed history of Diversified Trust CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 14,701 shares of TVTX stock, worth $271,527. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,701
Previous 11,532
27.48%
Holding current value
$271,527
Previous $161,000
59.01%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TVTX
# of Institutions
194Shares Held
83.7MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$141 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$141 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$127 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$86.5 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$80.2 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.19B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...